TwinBeech Capital’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-122,154
Closed -$7.21M 668
2025
Q2
$7.21M Buy
+122,154
New +$7.89M 0.16% 162
2024
Q2
Sell
-132,968
Closed -$7.13M 640
2024
Q1
$7.13M Buy
+132,968
New +$7.15M 0.15% 166
2023
Q4
Sell
-192,737
Closed -$9.57M 740
2023
Q3
$9.57M Buy
+192,737
New +$10.8M 0.18% 153
2023
Q2
Sell
-101,039
Closed -$5.72M 704
2023
Q1
$5.72M Buy
+101,039
New +$6.48M 0.12% 220
2021
Q3
Sell
-28,515
Closed -$2.21M 656
2021
Q2
$2.21M Buy
+28,515
New +$2.03M 0.27% 119
2020
Q4
Sell
-26,406
Closed -$1.31M 498
2020
Q3
$1.31M Buy
26,406
+16,309
+162% +$841K 0.28% 104
2020
Q2
$482K Buy
+10,097
New +$487K 0.11% 239

Other funds holding GMED

TwinBeech Capital's GMED Position: Q3 2025 in Review

TwinBeech Capital sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 122,154 shares — an estimated $7.21M sold.

TwinBeech Capital first reported a position in GMED in Q2 2020 and held it in 7 quarters. The position peaked at $9.57M in Q3 2023. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • TwinBeech Capital reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
  • TwinBeech Capital sold 122,154 Globus Medical shares in Q3 2025, an estimated $7.21M.
  • TwinBeech Capital first reported a position in Globus Medical in Q2 2020 and held it in 7 quarters.
  • TwinBeech Capital's Globus Medical position peaked at $9.57M in Q3 2023.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on TwinBeech Capital's 13F filing for Q3 2025, filed 14 Nov 2025.